世界の眼科用ドラッグデリバリーシステム市場インサイト及び予測(埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他)

◆英語タイトル:Global Ophthalmic Drug Delivery System Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09908)◆商品コード:QY22JLX09908
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:127
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、眼科用ドラッグデリバリーシステムのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼科用ドラッグデリバリーシステムの世界市場のxxx%を占める「埋め込み型眼科用ドラッグデリバリーシステム」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
眼科用ドラッグデリバリーシステムの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの眼科用ドラッグデリバリーシステム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

眼科用ドラッグデリバリーシステムのグローバル主要企業には、Aero Pump GmbH、AptarGroup、Bausch Health、Becton Dickinson & Company、EyePoint Pharmaceuticals, Inc.、Gaplast GmbH、Gerresheimer、Nemera、Nipro Corporation、Ocular Therapeutix、Owen Mumford、Silgan Holdings Inc.、Terumo Corporation、West Pharmaceutical Services, Inc.、Kedalion Therapeutics、Re-Vana Therapeutics、Mati Therapeutics, Inc.,、Biocorp Production、Ocumedic, Inc.、Graybug Vision、Taiwan Liposome、Santen Pharmaceutical、Envisia Therapeutics、Clearside Biomedicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

眼科用ドラッグデリバリーシステム市場は、種類と用途によって区分されます。世界の眼科用ドラッグデリバリーシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他

【用途別セグメント】
病院、クリニック、外来外科センター、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 眼科用ドラッグデリバリーシステム製品概要
- 種類別市場(埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他)
- 用途別市場(病院、クリニック、外来外科センター、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の眼科用ドラッグデリバリーシステム販売量予測2017-2028
- 世界の眼科用ドラッグデリバリーシステム売上予測2017-2028
- 眼科用ドラッグデリバリーシステムの地域別販売量
- 眼科用ドラッグデリバリーシステムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別眼科用ドラッグデリバリーシステム販売量
- 主要メーカー別眼科用ドラッグデリバリーシステム売上
- 主要メーカー別眼科用ドラッグデリバリーシステム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他)
- 眼科用ドラッグデリバリーシステムの種類別販売量
- 眼科用ドラッグデリバリーシステムの種類別売上
- 眼科用ドラッグデリバリーシステムの種類別価格
・用途別市場規模(病院、クリニック、外来外科センター、その他)
- 眼科用ドラッグデリバリーシステムの用途別販売量
- 眼科用ドラッグデリバリーシステムの用途別売上
- 眼科用ドラッグデリバリーシステムの用途別価格
・北米市場
- 北米の眼科用ドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別の眼科用ドラッグデリバリーシステム市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの眼科用ドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別の眼科用ドラッグデリバリーシステム市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の眼科用ドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別の眼科用ドラッグデリバリーシステム市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の眼科用ドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別の眼科用ドラッグデリバリーシステム市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの眼科用ドラッグデリバリーシステム市場規模(種類別、用途別)
- 主要国別の眼科用ドラッグデリバリーシステム市場規模(トルコ、サウジアラビア)
・企業情報
Aero Pump GmbH、AptarGroup、Bausch Health、Becton Dickinson & Company、EyePoint Pharmaceuticals, Inc.、Gaplast GmbH、Gerresheimer、Nemera、Nipro Corporation、Ocular Therapeutix、Owen Mumford、Silgan Holdings Inc.、Terumo Corporation、West Pharmaceutical Services, Inc.、Kedalion Therapeutics、Re-Vana Therapeutics、Mati Therapeutics, Inc.,、Biocorp Production、Ocumedic, Inc.、Graybug Vision、Taiwan Liposome、Santen Pharmaceutical、Envisia Therapeutics、Clearside Biomedical
・産業チェーン及び販売チャネル分析
- 眼科用ドラッグデリバリーシステムの産業チェーン分析
- 眼科用ドラッグデリバリーシステムの原材料
- 眼科用ドラッグデリバリーシステムの生産プロセス
- 眼科用ドラッグデリバリーシステムの販売及びマーケティング
- 眼科用ドラッグデリバリーシステムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 眼科用ドラッグデリバリーシステムの産業動向
- 眼科用ドラッグデリバリーシステムのマーケットドライバー
- 眼科用ドラッグデリバリーシステムの課題
- 眼科用ドラッグデリバリーシステムの阻害要因
・主な調査結果

Market Analysis and Insights: Global Ophthalmic Drug Delivery System Market
Due to the COVID-19 pandemic, the global Ophthalmic Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Implantable Ophthalmic Drug Delivery Systems accounting for % of the Ophthalmic Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Ophthalmic Drug Delivery System market size is valued at US$ million in 2021, while the US and Europe Ophthalmic Drug Delivery System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ophthalmic Drug Delivery System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera and Nipro Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ophthalmic Drug Delivery System Scope and Segment
Ophthalmic Drug Delivery System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ophthalmic Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Ophthalmic Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmic Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Implantable Ophthalmic Drug Delivery Systems
1.2.3 Particulate Ophthalmic Drug Delivery Systems
1.2.4 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Drug Delivery System Sales Estimates and Forecasts 2017-2028
2.2 Global Ophthalmic Drug Delivery System Revenue Estimates and Forecasts 2017-2028
2.3 Global Ophthalmic Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ophthalmic Drug Delivery System Sales by Region
2.4.1 Global Ophthalmic Drug Delivery System Sales by Region (2017-2022)
2.4.2 Global Sales Ophthalmic Drug Delivery System by Region (2023-2028)
2.5 Global Ophthalmic Drug Delivery System Revenue by Region
2.5.1 Global Ophthalmic Drug Delivery System Revenue by Region (2017-2022)
2.5.2 Global Ophthalmic Drug Delivery System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ophthalmic Drug Delivery System Sales by Manufacturers
3.1.1 Global Top Ophthalmic Drug Delivery System Manufacturers by Sales (2017-2022)
3.1.2 Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ophthalmic Drug Delivery System in 2021
3.2 Global Ophthalmic Drug Delivery System Revenue by Manufacturers
3.2.1 Global Ophthalmic Drug Delivery System Revenue by Manufacturers (2017-2022)
3.2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ophthalmic Drug Delivery System Revenue in 2021
3.3 Global Ophthalmic Drug Delivery System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ophthalmic Drug Delivery System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ophthalmic Drug Delivery System Sales by Type
4.1.1 Global Ophthalmic Drug Delivery System Historical Sales by Type (2017-2022)
4.1.2 Global Ophthalmic Drug Delivery System Forecasted Sales by Type (2023-2028)
4.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
4.2 Global Ophthalmic Drug Delivery System Revenue by Type
4.2.1 Global Ophthalmic Drug Delivery System Historical Revenue by Type (2017-2022)
4.2.2 Global Ophthalmic Drug Delivery System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
4.3 Global Ophthalmic Drug Delivery System Price by Type
4.3.1 Global Ophthalmic Drug Delivery System Price by Type (2017-2022)
4.3.2 Global Ophthalmic Drug Delivery System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ophthalmic Drug Delivery System Sales by Application
5.1.1 Global Ophthalmic Drug Delivery System Historical Sales by Application (2017-2022)
5.1.2 Global Ophthalmic Drug Delivery System Forecasted Sales by Application (2023-2028)
5.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
5.2 Global Ophthalmic Drug Delivery System Revenue by Application
5.2.1 Global Ophthalmic Drug Delivery System Historical Revenue by Application (2017-2022)
5.2.2 Global Ophthalmic Drug Delivery System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
5.3 Global Ophthalmic Drug Delivery System Price by Application
5.3.1 Global Ophthalmic Drug Delivery System Price by Application (2017-2022)
5.3.2 Global Ophthalmic Drug Delivery System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ophthalmic Drug Delivery System Market Size by Type
6.1.1 North America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
6.1.2 North America Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
6.2 North America Ophthalmic Drug Delivery System Market Size by Application
6.2.1 North America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
6.2.2 North America Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
6.3 North America Ophthalmic Drug Delivery System Market Size by Country
6.3.1 North America Ophthalmic Drug Delivery System Sales by Country (2017-2028)
6.3.2 North America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ophthalmic Drug Delivery System Market Size by Type
7.1.1 Europe Ophthalmic Drug Delivery System Sales by Type (2017-2028)
7.1.2 Europe Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Drug Delivery System Market Size by Application
7.2.1 Europe Ophthalmic Drug Delivery System Sales by Application (2017-2028)
7.2.2 Europe Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Drug Delivery System Market Size by Country
7.3.1 Europe Ophthalmic Drug Delivery System Sales by Country (2017-2028)
7.3.2 Europe Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Drug Delivery System Market Size by Type
8.1.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Type (2017-2028)
8.1.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
8.2 Asia Pacific Ophthalmic Drug Delivery System Market Size by Application
8.2.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Application (2017-2028)
8.2.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
8.3 Asia Pacific Ophthalmic Drug Delivery System Market Size by Region
8.3.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2017-2028)
8.3.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ophthalmic Drug Delivery System Market Size by Type
9.1.1 Latin America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
9.1.2 Latin America Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
9.2 Latin America Ophthalmic Drug Delivery System Market Size by Application
9.2.1 Latin America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
9.2.2 Latin America Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
9.3 Latin America Ophthalmic Drug Delivery System Market Size by Country
9.3.1 Latin America Ophthalmic Drug Delivery System Sales by Country (2017-2028)
9.3.2 Latin America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Type
10.1.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
10.2 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Application
10.2.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
10.3 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country
10.3.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aero Pump GmbH
11.1.1 Aero Pump GmbH Corporation Information
11.1.2 Aero Pump GmbH Overview
11.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aero Pump GmbH Recent Developments
11.2 AptarGroup
11.2.1 AptarGroup Corporation Information
11.2.2 AptarGroup Overview
11.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AptarGroup Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AptarGroup Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Corporation Information
11.3.2 Bausch Health Overview
11.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bausch Health Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bausch Health Recent Developments
11.4 Becton Dickinson & Company
11.4.1 Becton Dickinson & Company Corporation Information
11.4.2 Becton Dickinson & Company Overview
11.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Becton Dickinson & Company Recent Developments
11.5 EyePoint Pharmaceuticals, Inc.
11.5.1 EyePoint Pharmaceuticals, Inc. Corporation Information
11.5.2 EyePoint Pharmaceuticals, Inc. Overview
11.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments
11.6 Gaplast GmbH
11.6.1 Gaplast GmbH Corporation Information
11.6.2 Gaplast GmbH Overview
11.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Gaplast GmbH Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gerresheimer Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gerresheimer Recent Developments
11.8 Nemera
11.8.1 Nemera Corporation Information
11.8.2 Nemera Overview
11.8.3 Nemera Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nemera Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nemera Recent Developments
11.9 Nipro Corporation
11.9.1 Nipro Corporation Corporation Information
11.9.2 Nipro Corporation Overview
11.9.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Nipro Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nipro Corporation Recent Developments
11.10 Ocular Therapeutix
11.10.1 Ocular Therapeutix Corporation Information
11.10.2 Ocular Therapeutix Overview
11.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ocular Therapeutix Recent Developments
11.11 Owen Mumford
11.11.1 Owen Mumford Corporation Information
11.11.2 Owen Mumford Overview
11.11.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Owen Mumford Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Owen Mumford Recent Developments
11.12 Silgan Holdings Inc.
11.12.1 Silgan Holdings Inc. Corporation Information
11.12.2 Silgan Holdings Inc. Overview
11.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Silgan Holdings Inc. Recent Developments
11.13 Terumo Corporation
11.13.1 Terumo Corporation Corporation Information
11.13.2 Terumo Corporation Overview
11.13.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Terumo Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Terumo Corporation Recent Developments
11.14 West Pharmaceutical Services, Inc.
11.14.1 West Pharmaceutical Services, Inc. Corporation Information
11.14.2 West Pharmaceutical Services, Inc. Overview
11.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 West Pharmaceutical Services, Inc. Recent Developments
11.15 Kedalion Therapeutics
11.15.1 Kedalion Therapeutics Corporation Information
11.15.2 Kedalion Therapeutics Overview
11.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Kedalion Therapeutics Recent Developments
11.16 Re-Vana Therapeutics
11.16.1 Re-Vana Therapeutics Corporation Information
11.16.2 Re-Vana Therapeutics Overview
11.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Re-Vana Therapeutics Recent Developments
11.17 Mati Therapeutics, Inc.,
11.17.1 Mati Therapeutics, Inc., Corporation Information
11.17.2 Mati Therapeutics, Inc., Overview
11.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mati Therapeutics, Inc., Recent Developments
11.18 Biocorp Production
11.18.1 Biocorp Production Corporation Information
11.18.2 Biocorp Production Overview
11.18.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Biocorp Production Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Biocorp Production Recent Developments
11.19 Ocumedic, Inc.
11.19.1 Ocumedic, Inc. Corporation Information
11.19.2 Ocumedic, Inc. Overview
11.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Ocumedic, Inc. Recent Developments
11.20 Graybug Vision
11.20.1 Graybug Vision Corporation Information
11.20.2 Graybug Vision Overview
11.20.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Graybug Vision Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Graybug Vision Recent Developments
11.21 Taiwan Liposome
11.21.1 Taiwan Liposome Corporation Information
11.21.2 Taiwan Liposome Overview
11.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Taiwan Liposome Recent Developments
11.22 Santen Pharmaceutical
11.22.1 Santen Pharmaceutical Corporation Information
11.22.2 Santen Pharmaceutical Overview
11.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Santen Pharmaceutical Recent Developments
11.23 Envisia Therapeutics
11.23.1 Envisia Therapeutics Corporation Information
11.23.2 Envisia Therapeutics Overview
11.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Envisia Therapeutics Recent Developments
11.24 Clearside Biomedical
11.24.1 Clearside Biomedical Corporation Information
11.24.2 Clearside Biomedical Overview
11.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Clearside Biomedical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ophthalmic Drug Delivery System Industry Chain Analysis
12.2 Ophthalmic Drug Delivery System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ophthalmic Drug Delivery System Production Mode & Process
12.4 Ophthalmic Drug Delivery System Sales and Marketing
12.4.1 Ophthalmic Drug Delivery System Sales Channels
12.4.2 Ophthalmic Drug Delivery System Distributors
12.5 Ophthalmic Drug Delivery System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ophthalmic Drug Delivery System Industry Trends
13.2 Ophthalmic Drug Delivery System Market Drivers
13.3 Ophthalmic Drug Delivery System Market Challenges
13.4 Ophthalmic Drug Delivery System Market Restraints
14 Key Findings in The Global Ophthalmic Drug Delivery System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の眼科用ドラッグデリバリーシステム市場インサイト及び予測(埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他)(Global Ophthalmic Drug Delivery System Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。